Edition:
United States

Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

38.03USD
26 Aug 2016
Change (% chg)

$-0.05 (-0.13%)
Prev Close
$38.08
Open
$38.03
Day's High
$39.16
Day's Low
$37.08
Volume
208,701
Avg. Vol
229,094
52-wk High
$99.13
52-wk Low
$33.51

Select another date:

Tue, Aug 16 2016

BRIEF-Agios Pharmaceuticals appoints Andrew Hirsch as chief financial officer

* Glenn Goddard, senior vice president of finance, will be leaving company at end of September to pursue other opportunities

BRIEF-Agios Pharmaceuticals reports qtrly loss per share $1.47

* Collaboration revenue was $7.0 million for quarter ended June 30, 2016, compared to $13.2 million for comparable period in 2015

BRIEF-Agios Pharma reports initial data from phase 1 study of AG-519 in healthy volunteers

* Agios reports initial data from phase 1 study of ag-519 in healthy volunteers Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

BRIEF-Agios Pharmaceuticals, Celgene establish new collaboration in metabolic immuno-oncology

* Agios and Celgene establish new collaboration in metabolic immuno-oncology and amend certain rights from 2010 agreement

BRIEF-Agios sees 2016 ending cash position of more than $390 mln

* Expects 2016 ending cash position of more than $390 million

BRIEF-Agios, Celgene Corp to defer selection process for allocating rights to certain discovery programs

* Co and Celgene Corp agreed to defer from April 14, 2016 to June 1, 2016 selection process for allocating rights to certain discovery programs

Select another date: